DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

DGAP-News: MorphoSys AG / Key word(s): Agreement
MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

14.06.2022 / 22:01
The issuer is solely responsible for the content of this announcement.
Quelle: Börse Online RSS Feed